Pulmagen Therapeutics   Report issue

For profit Phase 2
Founded: Slough United Kingdom (2010)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2010
NCT00634413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now